Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur John P. 2nd HEGARTY |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Beta-adrenergic antagonism alters functional connectivity during associative processing in a preliminary study of individuals with and without autism / John P. 2nd HEGARTY in Autism, 24-3 (April 2020)
[article]
Titre : Beta-adrenergic antagonism alters functional connectivity during associative processing in a preliminary study of individuals with and without autism Type de document : Texte imprimé et/ou numérique Auteurs : John P. 2nd HEGARTY, Auteur ; Rachel M. ZAMZOW, Auteur ; Bradley J. FERGUSON, Auteur ; Shawn E. CHRIST, Auteur ; Eric C. PORGES, Auteur ; Jeffrey D. JOHNSON, Auteur ; David Q. BEVERSDORF, Auteur Article en page(s) : p.795-801 Langues : Anglais (eng) Mots-clés : beta-blockers fronto-parietal control network functional magnetic resonance imaging noradrenergic propranolol semantic fluency Index. décimale : PER Périodiques Résumé : Beta-adrenergic antagonism (e.g. propranolol) has been associated with cognitive/behavioral benefits following stress-induced impairments and for some cognitive/behavioral domains in individuals with autism spectrum disorder. In this preliminary investigation, we examined whether the benefits of propranolol are associated with functional properties in the brain. Adolescents/adults (mean age = 22.54 years) with (n = 13) and without autism spectrum disorder (n = 13) attended three sessions in which propranolol, nadolol (beta-adrenergic antagonist that does not cross the blood-brain barrier), or placebo was administered before a semantic fluency task during functional magnetic resonance imaging. Autonomic nervous system measures and functional connectivity between language/associative processing regions and within the fronto-parietal control, dorsal attention, and default mode networks were examined. Propranolol was associated with improved semantic fluency performance, which was correlated with the baseline resting heart rate. Propranolol also altered network efficiency of regions associated with semantic processing and in an exploratory analysis reduced functional differences in the fronto-parietal control network in individuals with autism spectrum disorder. Thus, the cognitive benefits from beta-adrenergic antagonism may be generally associated with improved information processing in the brain in domain-specific networks, but individuals with autism spectrum disorder may also benefit from additional improvements in domain-general networks. The benefits from propranolol may also be able to be predicted from baseline autonomic nervous system measures, which warrants further investigation. En ligne : http://dx.doi.org/10.1177/1362361319868633 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=422
in Autism > 24-3 (April 2020) . - p.795-801[article] Beta-adrenergic antagonism alters functional connectivity during associative processing in a preliminary study of individuals with and without autism [Texte imprimé et/ou numérique] / John P. 2nd HEGARTY, Auteur ; Rachel M. ZAMZOW, Auteur ; Bradley J. FERGUSON, Auteur ; Shawn E. CHRIST, Auteur ; Eric C. PORGES, Auteur ; Jeffrey D. JOHNSON, Auteur ; David Q. BEVERSDORF, Auteur . - p.795-801.
Langues : Anglais (eng)
in Autism > 24-3 (April 2020) . - p.795-801
Mots-clés : beta-blockers fronto-parietal control network functional magnetic resonance imaging noradrenergic propranolol semantic fluency Index. décimale : PER Périodiques Résumé : Beta-adrenergic antagonism (e.g. propranolol) has been associated with cognitive/behavioral benefits following stress-induced impairments and for some cognitive/behavioral domains in individuals with autism spectrum disorder. In this preliminary investigation, we examined whether the benefits of propranolol are associated with functional properties in the brain. Adolescents/adults (mean age = 22.54 years) with (n = 13) and without autism spectrum disorder (n = 13) attended three sessions in which propranolol, nadolol (beta-adrenergic antagonist that does not cross the blood-brain barrier), or placebo was administered before a semantic fluency task during functional magnetic resonance imaging. Autonomic nervous system measures and functional connectivity between language/associative processing regions and within the fronto-parietal control, dorsal attention, and default mode networks were examined. Propranolol was associated with improved semantic fluency performance, which was correlated with the baseline resting heart rate. Propranolol also altered network efficiency of regions associated with semantic processing and in an exploratory analysis reduced functional differences in the fronto-parietal control network in individuals with autism spectrum disorder. Thus, the cognitive benefits from beta-adrenergic antagonism may be generally associated with improved information processing in the brain in domain-specific networks, but individuals with autism spectrum disorder may also benefit from additional improvements in domain-general networks. The benefits from propranolol may also be able to be predicted from baseline autonomic nervous system measures, which warrants further investigation. En ligne : http://dx.doi.org/10.1177/1362361319868633 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=422